{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:28Z","timestamp":1787026828066,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"\n Objective<\/jats:title>\n To compare homocysteine (Hcy) and uric acid (UA) levels between patients with Parkinson\u2019s disease with cognitive impairment (PD-CI) and those with post-stroke cognitive impairment (PS-CI), and to analyze the correlation of these biomarkers with cognitive function and their heterogeneity across different disease types.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Patients diagnosed with cognitive impairment who were admitted to the Department of Neurology at Yangjiang Hospital of Traditional Chinese Medicine between January 2025 and December 2025 were included (60 PD-CI; 60 PS-CI). Blood Hcy and UA levels were uniformly measured, and cognitive function was assessed using the Mini-Mental State Examination (MMSE). Covariance analysis compared biomarker level differences between groups. Spearman correlation analysis and multivariate linear regression models with interaction terms explored the relationship between biomarkers and MMSE scores. Binary logistic regression identified factors independently associated with disease type.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n After adjusting for confounding factors, the PD-CI group exhibited significantly higher Hcy levels (adjusted mean difference: 2.55\u202f\u03bcmol\/L, 95% CI: 0.23\u20134.87,\n p<\/jats:italic>\n \u202f=\u202f0.032), while UA levels were significantly lower (adjusted mean difference: \u221234.66\u202f\u03bcmol\/L, 95% CI: \u221263.87 to \u22125.46,\n p<\/jats:italic>\n \u202f=\u202f0.020). In the overall sample, Hcy negatively correlated with MMSE (\n r<\/jats:italic>\n \u202f=\u202f\u22120.309,\n p<\/jats:italic>\n \u202f=\u202f0.001). This association was numerically stronger in the PD-CI group (\n r<\/jats:italic>\n \u202f=\u202f\u22120.456,\n p<\/jats:italic>\n \u202f&lt;\u202f0.001) and weaker in the PS-CI group (\n r<\/jats:italic>\n \u202f=\u202f\u22120.175,\n p<\/jats:italic>\n \u202f=\u202f0.180). However, the difference in correlation coefficients between the two groups did not reach statistical significance (\n p<\/jats:italic>\n =\u202f0.093). UA levels showed no significant linear or nonlinear association with MMSE scores in either group. Multivariate regression analysis confirmed that elevated Hcy levels maintained a persistent negative correlation with MMSE scores in both groups. Low educational attainment, absence of hypertension, and lower UA levels were identified as independently associated with PD-CI (compared to PS-CI).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Patients with PD-CI and PS-CI exhibit distinct metabolic profiles, with the PD-CI group characterized by elevated Hcy and low UA levels. Although elevated Hcy is a common factor associated with cognitive impairment in both conditions, UA levels in this cohort were independently associated with PD-CI (relative to PS-CI), not with MMSE scores. These findings suggest potential differences in metabolic profiles and may offer new insights for clinical differential diagnosis. As an exploratory cross-sectional analysis, these findings require validation in prospective studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fneur.2026.1819930","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:29:55Z","timestamp":1777004995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative characteristics of homocysteine and uric acid in patients with Parkinson\u2019s disease-related cognitive impairment and post-stroke cognitive impairment"],"prefix":"10.3389","volume":"17","author":[{"given":"Jinbang","family":"Zhan","sequence":"first","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Guan","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Lin","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Yang","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yuan","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[{"name":"Yangjiang Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine","place":["Yangjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41582-025-01163-x","article-title":"Characteristics and mechanisms of cognitive impairment in Parkinson disease","volume":"22","author":"Oikonomou","year":"2026","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1161\/STROKEAHA.123.044297","article-title":"White matter hyperintensity volume and poststroke cognition: an individual patient data pooled analysis of 9 ischemic stroke cohort studies","volume":"54","author":"de Kort","year":"2023","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1661370","DOI":"10.3389\/fnagi.2026.1661370","article-title":"Dynamic trends, spatial clustering, and multi-model projections of the global burden of Alzheimer's disease and other dementias: an analysis of GBD 1990-2021 data to 2050","volume":"18","author":"Xiang","year":"2026","journal-title":"Front Aging Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/ijms26083672","article-title":"Impact of alterations in homocysteine, asymmetric dimethylarginine and vitamins-related pathways in some neurodegenerative diseases: a narrative review","volume":"26","author":"Saija","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.21037\/qims-24-1736","article-title":"Association between third ventricular width assessed by transcranial sonography and plasma homocysteine in Parkinson's disease with cognitive impairment and their potential to predict conversion to dementia","volume":"15","author":"Hou","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1611140","DOI":"10.3389\/fneur.2025.1611140","article-title":"Joint effects of elevated homocysteine levels and low eGFR on post-stroke cognitive impairment","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12964-024-01965-4","article-title":"Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"23","author":"Xu","year":"2025","journal-title":"Cell Commun Signal"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.jnha.2024.100319","article-title":"Serum uric acid levels associated with outcomes of neurodegenerative disorders and brain health: findings from the UK biobank","volume":"28","author":"Jiang","year":"2024","journal-title":"J Nutr Health Aging"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/npr2.12445","article-title":"Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: a new perspective","volume":"44","author":"Alrouji","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12888-021-03495-6","article-title":"A comparison of the Mini-mental state examination (MMSE) with the Montreal cognitive assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study","volume":"21","author":"Jia","year":"2021","journal-title":"BMC Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00415-016-8370-2","article-title":"MDS clinical diagnostic criteria for Parkinson's disease in China","volume":"264","author":"Li","year":"2017","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/svn-2023-002998","article-title":"Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update","volume":"8","author":"Liu","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3969\/j.issn.1673-5765.2021.04.011","article-title":"Expert consensus on management of post-stroke cognitive impairment 2021","volume":"16","author":"Wang","year":"2021","journal-title":"Chin J Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"680531","DOI":"10.3389\/fgene.2021.680531","article-title":"The neurocognitive study for the aging: longitudinal analysis on the contribution of sex, age, education and APOE \u025b4 on cognitive performance","volume":"12","author":"Chadjikyprianou","year":"2021","journal-title":"Front Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12877-025-06326-5","article-title":"Association between estimated glomerular filtration rate and memory function mediated by brain Gray matter volumes: a cross-sectional study using the ADNI database","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Geriatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"103807","DOI":"10.1016\/j.numecd.2024.103807","article-title":"The relationship between serum uric acid and homocysteine is influenced by kidney function","volume":"35","author":"Zhao","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2147\/NDT.S460938","article-title":"Nonlinear relationship between homocysteine and mild cognitive impairment in early parkinson's disease: a cross-sectional study","volume":"20","author":"Ouyang","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1378334","DOI":"10.3389\/fneur.2024.1378334","article-title":"Progression of cognitive impairment in Parkinson\u2019s disease correlates with uric acid concentration","volume":"15","author":"Zhai","year":"2024","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2147\/NDT.S508965","article-title":"Severity and prognosis of vascular dementia in patients with acute cerebral infarction combined with H-type hypertension and its correlation with uric acid levels","volume":"21","author":"Hong","year":"2025","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"105357","DOI":"10.1016\/j.parkreldis.2023.105357","article-title":"Levodopa, homocysteine and Parkinson's disease: what's the problem?","volume":"109","author":"Ahlskog","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu15040901","article-title":"Two faces of catechol-O-methyltransferase inhibitor on one-carbon metabolism in parkinson's disease: a meta-analysis","volume":"15","author":"Kim","year":"2023","journal-title":"Nutrients"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00702-023-02684-9","article-title":"Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations","volume":"130","author":"Phokaewvarangkul","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.neuropharm.2025.110685","article-title":"Inhibiting MARS attenuates hyperhomocysteinemia-associated neurodegeneration in Parkinson's disease","volume":"281","author":"Guo","year":"2025","journal-title":"Neuropharmacology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1604378","DOI":"10.3389\/fnagi.2025.1604378","article-title":"NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies","volume":"17","author":"Zhang","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"107253","DOI":"10.1016\/j.jbc.2024.107253","article-title":"Homocysteine-induced sustained GluN2A NMDA receptor stimulation leads to mitochondrial ROS generation and neurotoxicity","volume":"300","author":"Deep","year":"2024","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/nu17010040","article-title":"Hyperhomocysteinemia: underlying links to stroke and hydrocephalus, with a focus on polyphenol-based therapeutic approaches","volume":"17","author":"Ortiz-Salguero","year":"2024","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1523\/JNEUROSCI.1333-22.2023","article-title":"Targeting astrocyte signaling alleviates cerebrovascular and synaptic function deficits in a diet-based mouse model of small cerebral vessel disease","volume":"43","author":"Sompol","year":"2023","journal-title":"J Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.31083\/j.jin2309168","article-title":"Relationships between serum lipid, uric acid levels and mild cognitive impairment in parkinson's disease and multiple system atrophy","volume":"23","author":"Ren","year":"2024","journal-title":"J Integr Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/MCO.0000000000001151","article-title":"Assessing systemic inflammation and its prognostic value: Glasgow prognostic score, neutrophil-to-lymphocyte ratio or other options?","volume":"28","author":"Muscaritoli","year":"2025","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/antiox14040483","article-title":"Xanthine oxidoreductase: a double-edged sword in neurological diseases","volume":"14","author":"Bortolotti","year":"2025","journal-title":"Antioxidants"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1186\/s12967-024-05800-9","article-title":"Gut commensal Parabacteroides distasonis exerts neuroprotective effects in acute ischemic stroke with hyperuricemia via regulating gut microbiota-gut-brain axis","volume":"22","author":"Wei","year":"2024","journal-title":"J Transl Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.12779\/dnd.2023.22.2.69","article-title":"Effect of education on discriminability of Montreal cognitive assessment compared to Mini-mental state examination","volume":"22","author":"Kim","year":"2023","journal-title":"Dement Neurocogn Disord"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/psyg.13069","article-title":"Examining the validity of the Mini-mental state examination (MMSE) and its domains using network analysis","volume":"24","author":"Truong","year":"2024","journal-title":"Psychogeriatrics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.metip.2023.100120","article-title":"Use and misuse of corrections for multiple testing","volume":"8","author":"Garc\u00eda-P\u00e9rez","year":"2023","journal-title":"Methods Psychol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1819930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:29:56Z","timestamp":1777004996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1819930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":36,"alternative-id":["10.3389\/fneur.2026.1819930"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1819930","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1819930"}}